Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse

The Clinical Investigator

Volumn 70, Issue 3-4, 1992, Pages 232-238

  Janson, A M ^a   Fuxe, K ^a   Goldstein, M ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Degeneration; Dopamine; MPTP; Neostriatum; Protection; Substantia nigra

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; MECAMYLAMINE; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CIGARETTE SMOKING; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG EFFECT; MALE; MOUSE; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 3,4-DIHYDROXYPHENYLACETIC ACID; ANIMAL; DOPAMINE; DRUG TOLERANCE; HOMOVANILLIC ACID; INFUSION PUMPS; MALE; MECAMYLAMINE; MICE; MICE, INBRED C57BL; MPTP POISONING; NICOTINE; PARKINSON DISEASE, SECONDARY; RECEPTORS, NICOTINIC; SUBSTANTIA NIGRA; SUPPORT, NON-U.S. GOV'T;

EID: 0026528017     PISSN: 09410198     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/BF00184656     Document Type: Article

References (27)

1. Cigarette smoking and Parkinson's disease
2. Cigarette smoking and Parkinson's disease: a comparison of cases with matched neighbors
3. Calcium-mediated cytotoxicity: relationship to specific channel types and role in ischemic damage
4. Simultaneous determination of nicotine and cotinine in plasma using capillary column gas chromatography with nitrogen-sensitive detection
5. N-methyl-4-phenylpyridine (MMP+) together with 6-hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria
6. Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection
7. Smoking and Parkinson's disease
8. Temporal lobe epilepsy, excitotoxins and the mechanism of selective neuronal loss
9. Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse
10. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity
11. Phosphorylation of the nicotinic acetylcholine receptor regulates its rate of desensitization
12. Morphometric studies on the protective action of nicotine on the substantia nigra dopamine nerve cells after partial hemitransection in the male rat
13. Chronic nicotine treatment counteracts the disappearance of tyrosinehydroxylase immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection
14. Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse
15. The effect of chronic nicotine treatment on 1-methyl4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse
16. Parkinsonism-inducing neurotoxin N-methyl-4-phenyl1,2,3,6-tetrahydropyridine: uptake of the metabolite 1-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity
17. The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium
18. Liquid chromatographic analysis of catecholamines — routine assay of regional brain mapping
19. Intraneuronal generation of a pyridinum metabolite may cause drug-induced parkinsonism
20. The treatment of postencephalitic parkinsonism by nicotine
21. Calcium influx mediated by nicotinic receptors and voltage sensitive calcium channels in SK-N-SH human neuroblastoma cells
22. Functional organization of the acetylcholine receptor: a model of ligand gated ion channel
23. Behavioral and biochemical effects of nicotine in an MPTP-induced mouse model of Parkinson's disease
24. Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse